Erweiterte Suche

Gegenwärtig bekleidet Francesco Tanzi die Position des Chief Financial Officer & Executive Vice President von Pirelli & C. SpA und des Präsidenten von ADB Broadband SpA. Er ist außerdem Mitglied des Vorstands von Pirelli International Plc. Zuvor war er Director-Finance bei Telecom Italia SpA. Er erwarb einen Bachelor-Abschluss an der Universität von Bocconi.

Stefano Tanzi is the founder of Fattore Italia SRL.
He is currently an Independent Director at IDeAMI SPA.
Previously, he worked as a Director at Nordest Merchant SpA, an Independent Director at Banca Ifigest SpA, a Managing Partner at 21 Invest SGR SPA, the Head of Corporate Finance at KPMG SpA, and a Vice President at 21 Invest SpA.

Rudolph Emile Tanzi is the founder of NeuroGenetic Pharmaceuticals, Inc. (founded in 2009) and Acta Pharmaceuticals, Inc. (founded in 2022).
At Acta Pharmaceuticals, Inc., he holds the title of Director.
Dr. Tanzi is also the founder of REACT Neuro, Inc., MarvelBiome, Inc...
He currently holds the position of Vice Chairman-Neurology Department at The General Hospital Corp.
and is a Professor-Neurology at Harvard Medical School.
Dr. Tanzi's former position was as a Director at TorreyPines Therapeutics, Inc.

Selcuk Tanzi is currently the Director of Business Development at Forte Bilgi Iletisim Teknolojileri ve Savunma Sanayi.
AS since 2020.
He is also currently the Assistant General Manager at L&N Bilgisayar Ve Danismanlik Hizmetleri San Tic AS since 2007.
Previously, he worked as a Sales Director at Teknoser Bilgisayar Teknik Hizmetler Sanayi ve Dis Ticaret AS.
Mr. Tanzi received his undergraduate degree from Ankara University in 2003.

Lisa M.
Tanzi currently works as a Secretary & Group Chief Compliance Officer at Sirius International Insurance Group Ltd.

Rudy Tanzi is the founder of Cognitive Clarity, Inc. (founded in 2015).
He is currently the Director-McCance Center For Brain Health at The General Hospital Corp., a member of the Scientific Advisory Board at Dolby Family Ventures LLC, the Founding Chair & Scientific Advisory Board at Amylyx Pharmaceuticals, Inc. (since 2014), and a Professor at Harvard Medical School.
He completed his undergraduate degree at Rochester Christian University.

Vito Tanzi is currently a Director at Soroban Cayman Fund Ltd.
and the Chief Operating Officer & Chief Financial Officer at Soroban Capital Partners LP since 2010.
He was previously the Chief Financial Officer at Blackstone Kailix Advisors LLC from 2007 to 2008, Vice President at Goldman Sachs & Co. LLC from 1998 to 2006, Senior Accountant at Goldstein Golub Kessler & Co. from 1996 to 1998, and Chief Operating Officer at Kailix Investment Advisors LLC from 2009 to 2010.
Tanzi received his undergraduate degree from Zicklin School of Business in 1993.